Jan 30, 2021 | Featured, Medicare, Uncategorized
On this episode of the podcast, Terry and Bob discuss drug pricing in Washington D.C. There are many potential paths that drug pricing reform may take in the next couple of years with competing pieces of legislation in the House of Representatives and the Senate. They...
Dec 26, 2020 | Featured, Federal Issues, Medicare, Podcast
On this episode of the podcast, Terry and Bob discuss President Trump’s “most favored nations” rule which ties federal reimbursements for Medicare Part B drugs to other developed nations’ prices. In other words, this rule is a de facto price...
Dec 21, 2020 | Featured, Medicare
On November 20, 2020, the Center for Medicare & Medicaid Services’ (CMS) Innovation Center announced a mandatory national model that will evaluate whether reimbursing care providers for Medicare Part B drugs at rates that match international prices would reduce...
Jul 25, 2020 | COVID-19, Featured, Medicare, Podcast
On this episode of the podcast, Terry and Bob discuss how the Covid-19 pandemic can accelerate the movement toward value-based medical care and digital medical technologies. Bob speaks with Dr. Mark McClellan, former FDA and CMS chief and current director of the...
Jun 22, 2020 | Medicare, Out of Pocket Costs
About 54 million Americans are estimated to be suffering from, or are at a high risk for, osteoporosis—a disease characterized by weak bones that are susceptible to fractures. In addition to a healthy diet, preventive screening is recommended to reduce the risk of...
